ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC022431.2 | Uncharacterized protein LOC101928448 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ACOT4 | Acyl-CoA thioesterase 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ACOT6 | Acyl-CoA thioesterase 6 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAMTSL2 | ADAMTS-like 2 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGMAT | Agmatine ureohydrolase (agmatinase) | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALX1 | ALX homeobox 1 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ARSE | Arylsulfatase E (chondrodysplasia punctata 1) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ASPA | Aspartoacylase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ASPDH | Aspartate dehydrogenase domain containing | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
B3GNT4 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C10orf126 | Chromosome 10 open reading frame 126 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C14orf37 | Chromosome 14 open reading frame 37 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C21orf62 | Chromosome 21 open reading frame 62 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA12 | Carbonic anhydrase XII | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CALCR | Calcitonin receptor | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CCDC64 | Coiled-coil domain containing 64 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDH6 | Cadherin 6, type 2, K-cadherin (fetal kidney) | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CGNL1 | Cingulin-like 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CHDH | Choline dehydrogenase | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN24 | Claudin 24 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN8 | Claudin 8 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLNK | Cytokine-dependent hematopoietic cell linker | Predicted intracellular proteins
| | | | | Tissue enhanced |
COL4A3 | Collagen, type IV, alpha 3 (Goodpasture antigen) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRB2 | Crumbs family member 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
DMRT2 | Doublesex and mab-3 related transcription factor 2 | Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
EFHD1 | EF-hand domain family, member D1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ENAM | Enamelin | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ENPP6 | Ectonucleotide pyrophosphatase/phosphodiesterase 6 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ESM1 | Endothelial cell-specific molecule 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
ESRRB | Estrogen-related receptor beta | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ESRRG | Estrogen-related receptor gamma | FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ETNK2 | Ethanolamine kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
EXOC3L2 | Exocyst complex component 3-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM131C | Family with sequence similarity 131, member C | Predicted intracellular proteins
| | | | | Tissue enhanced |
FCAMR | Fc receptor, IgA, IgM, high affinity | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FGF9 | Fibroblast growth factor 9 | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |